Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil
Tae-Young Hwang, Inn-Sook Ahn, Seonwoo Kim, Doh Kwan Kim
Psychiatry Investig. 2016;13(3):341-348.   Published online 2016 May 18     DOI: https://doi.org/10.4306/pi.2016.13.3.341
Gender differences in Parkinson's disease with dementia and dementia with Lewy bodies
Lidadi L. Agbomi, Chika P. Onuoha, Samuel I. Nathaniel, Oreoluwa O. Coker-Ayo, Melissa J. Bailey-Taylor, Laurie Theriot Roley, Nicolas Poupore, Richard L. Goodwin, Thomas I. Nathaniel
Aging and Health Research.2022; 2(4): 100096.     CrossRef
Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease
Sneha Mantri, Michelle Fullard, Shelly L. Gray, Daniel Weintraub, Rebecca A. Hubbard, Sean Hennessy, Allison W. Willis
JAMA Neurology.2019; 76(1): 41.     CrossRef
A review of clinical treatment considerations of donepezil in severe Alzheimer's disease
Aida Adlimoghaddam, Melanie Neuendorff, Banibrata Roy, Benedict C. Albensi
CNS Neuroscience & Therapeutics.2018; 24(10): 876.     CrossRef
Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined
Patricia B. de la Tremblaye, Corina O. Bondi, Naima Lajud, Jeffrey P. Cheng, Hannah L. Radabaugh, Anthony E. Kline
Journal of Neurotrauma.2017; 34(8): 1610.     CrossRef